Search

Your search keyword '"Worm, Margitta"' showing total 1,904 results

Search Constraints

Start Over You searched for: Author "Worm, Margitta" Remove constraint Author: "Worm, Margitta"
1,904 results on '"Worm, Margitta"'

Search Results

3. Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study

5. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.

7. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

10. Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

11. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

13. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

16. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis

17. Tolerance induction through early feeding to prevent food allergy in infants and children with sensitization against food allergens (TIFFANI): rationale, study design, and methods of a randomized controlled trial

20. Global disparities in availability of epinephrine auto-injectors

22. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

23. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

29. Title of Article: Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”

30. S2k guideline: Diagnosis and therapy of localized scleroderma

31. Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study

32. Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial

33. Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry

37. Managing food allergy: GA2LEN guideline 2022

39. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.

40. Contact allergies to dental materials in patients.

41. Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis

42. 561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

43. 566 - Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial

44. Food allergy outside the eight big foods in Europe: A systematic review and meta‐analysis

45. Global distribution of physician-diagnosed adult-onset food allergy: results from the international, cross-sectional prevalence and severity study of pediatric and adult IgE-mediated food allergies (ASSESS FA)

46. 523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD)

47. Risk Stratification of Food Allergy Patients: Results from the International, Cross-sectional Prevalence and Severity Study of Pediatric and Adult IgE-Mediated Food Allergies (ASSESS FA)

48. S3‐Leitlinie Atopische Dermatitis: Teil 2 ‐ Systemische Therapie

49. S3 Guideline Atopic dermatitis: Part 1 ‐ General aspects, topical and non‐drug therapies, special patient groups

50. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

Catalog

Books, media, physical & digital resources